In the wake of acting White House Chief of Staff Mick Mulvaney’s announcement this Thursday that next year’s G7 summit will be hosted at President Trump’s Doral golf club, Fox News senior judicial analyst Andrew Napolitano pointed out that Trump would be violating the emoluments clause if he were to go through with the move.
At the outset of the segment, Fox Business Network anchor Neil Cavuto said that the announcement is “effectively saying the president has given himself this contract.”
According to Napolitano, the Constitution “does not address profits, it addresses any present, as in a gift, any emolument as in cash of any kind whatever. I’m quoting the emoluments clause, from any king, prince or foreign state.”
“[Trump] has bought himself an enormous headache now with the choice of this,” he continued. “This is about as direct and profound a violation of the emoluments clause as one could create.”
Watch the segment below, via the Daily Beast:
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.